Web-based training and certification of clinical staff during the randomised clinical trial SafeBoosC-III.
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
23 Oct 2024
23 Oct 2024
Historique:
received:
20
05
2024
accepted:
07
10
2024
medline:
24
10
2024
pubmed:
24
10
2024
entrez:
24
10
2024
Statut:
epublish
Résumé
SafeBoosC-III is a pragmatic, multinational clinical trial evaluating cerebral oximetry-guided treatment for extremely preterm infants. In total, 1601 infants were randomised across 70 sites in Asia, Europe, and USA. To enhance data quality and patient care, a web-based training program was implemented for staff. We now report on the processes. All training modules consisted of initial learning material followed by a case-based quiz, with elaborate responses to correct as well as to wrong answers. Modules covered trial introduction, cerebral oximetry monitoring, treatment guidelines, cerebral ultrasound, and Good Clinical Practice. The introduction module was accessible in eight languages on an online platform, while language versions varied for other modules, due to different needs. Certification was earned upon module completion, relevant to the staff category. The training was not mandatory, but for motivational purposes, principal investigators continuously received local certification rate reports. A total of 926 out of 2347 staff (39%) obtained certification. Amongst 295 staff who completed the evaluation, 83% rated the program as overall good and 94% found it relevant to clinical practice. Sites exhibited varying certification rates, with 10 at 0%, 43 between 0.1 and 79.9%, and 17 exceeding 80%. There was no correlation between the rate of certification in individual sites and how often the clinical management was changed due to cerebral hypoxia nor a correlation to site-specific estimates of the intervention effect. Despite language barriers and a low budget, our web-based training and certification program proved feasible. Only a minority of sites reached 80% certification of staff and an impact on the trial could not be detected. The SafeBoosC-III trial is registered at ClinicalTrials.gov NCT03770741. The first participant was randomised in June 2019 and recruitment was completed in December 2021.
Sections du résumé
BACKGROUND
BACKGROUND
SafeBoosC-III is a pragmatic, multinational clinical trial evaluating cerebral oximetry-guided treatment for extremely preterm infants. In total, 1601 infants were randomised across 70 sites in Asia, Europe, and USA. To enhance data quality and patient care, a web-based training program was implemented for staff. We now report on the processes.
METHODS
METHODS
All training modules consisted of initial learning material followed by a case-based quiz, with elaborate responses to correct as well as to wrong answers. Modules covered trial introduction, cerebral oximetry monitoring, treatment guidelines, cerebral ultrasound, and Good Clinical Practice. The introduction module was accessible in eight languages on an online platform, while language versions varied for other modules, due to different needs. Certification was earned upon module completion, relevant to the staff category. The training was not mandatory, but for motivational purposes, principal investigators continuously received local certification rate reports.
RESULTS
RESULTS
A total of 926 out of 2347 staff (39%) obtained certification. Amongst 295 staff who completed the evaluation, 83% rated the program as overall good and 94% found it relevant to clinical practice. Sites exhibited varying certification rates, with 10 at 0%, 43 between 0.1 and 79.9%, and 17 exceeding 80%. There was no correlation between the rate of certification in individual sites and how often the clinical management was changed due to cerebral hypoxia nor a correlation to site-specific estimates of the intervention effect.
CONCLUSION
CONCLUSIONS
Despite language barriers and a low budget, our web-based training and certification program proved feasible. Only a minority of sites reached 80% certification of staff and an impact on the trial could not be detected.
TRIAL REGISTRATION
BACKGROUND
The SafeBoosC-III trial is registered at ClinicalTrials.gov NCT03770741. The first participant was randomised in June 2019 and recruitment was completed in December 2021.
Identifiants
pubmed: 39444031
doi: 10.1186/s13063-024-08530-x
pii: 10.1186/s13063-024-08530-x
doi:
Banques de données
ClinicalTrials.gov
['NCT03770741']
Types de publication
Journal Article
Multicenter Study
Pragmatic Clinical Trial
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
711Investigateurs
Adelina Pellicer
(A)
Afif El-Kuffash
(A)
Agata Bargiel
(A)
Ana Alarcon
(A)
Andrew Hopper
(A)
Anita Truttmann
(A)
Anja Hergenhan
(A)
Anja Klamer
(A)
Anna Curley
(A)
Anne Marie Heuchan
(AM)
Anne Smits
(A)
Asli Cinar Memisoglu
(AC)
Barbara Krolak-Olejnik
(B)
Beata Rzepecka
(B)
Begona Loureiro Gonzales
(BL)
Beril Yasa
(B)
Berndt Urlesberger
(B)
Catalina Morales-Betancourt
(C)
Chantal Lecart
(C)
Christian Gluud
(C)
Claudia Knöepfli
(C)
Cornelia Hagmann
(C)
David Healy
(D)
Ebru Ergenekon
(E)
Eleftheria Hatzidaki
(E)
Elena Bergon-Sendin
(E)
Eleni Skylogianni
(E)
Elzbieta Rafinska-Wazny
(E)
Emmanuele Mastretta
(E)
Eugene Dempsey
(E)
Eva Valverde
(E)
Evangelina Papathoma
(E)
Fabio Mosca
(F)
Gabriel Dimitriou
(G)
Gerhard Pichler
(G)
Giovanni Vento
(G)
Gitte Holst Hahn
(GH)
Gunnar Naulaers
(G)
Guoqiang Cheng
(G)
Hans Fuchs
(H)
Hilal Ozkan
(H)
Isabel De Las Cuevas
(I)
Itziar Serrano-Vinuales
(I)
Iwona Sadowska-Krawczenko
(I)
Jachym Kucera
(J)
Jakub Tkaczyk
(J)
Jan Miletin
(J)
Jan Sirc
(J)
Janus Christian Jakobsen
(JC)
Jana Baumgartner
(J)
Jonathan Mintzer
(J)
Julie De Buyst
(J)
Karen McCall
(K)
Konstantina Tsoni
(K)
Kosmas Sarafidis
(K)
Lars Bender
(L)
Laura Serrano Lopez
(LS)
Le Wang
(L)
Liesbeth Thewissen
(L)
Lin Huijia
(L)
Lina Chalak
(L)
Ling Yang
(L)
Luc Cornette
(L)
Luis Arruza
(L)
Maria Wilinska
(M)
Mariana Baserga
(M)
Marta Mencia Ybarra
(MM)
Marta Teresa Palacio
(MT)
Martin Stocker
(M)
Massimo Agosti
(M)
Merih Cetinkaya
(M)
Miguel Alsina
(M)
Monica Fumagalli
(M)
Munaf M Kadri
(MM)
Mustafa Senol Akin
(MS)
Münevver Baş
(M)
Nilgun Koksal
(N)
Olalla Otero Vaccarello
(OO)
Olivier Baud
(O)
Pamela Zafra
(P)
Peter Agergaard
(P)
Peter Korcek
(P)
Pierre Maton
(P)
Rebeca Sanchez-Salmador
(R)
Ruth Del Rio Florentino
(R)
Ryszard Lauterbach
(R)
Salvador Piris Borregas
(SP)
Saudamini Nesargi
(S)
Serife Suna
(S)
Shashidhar Appaji Rao
(SA)
Shujuan Zeng
(S)
Silvia Pisoni
(S)
Simon Hyttel-Sørensen
(S)
Sinem Gulcan Kersin
(SG)
Siv Fredly
(S)
Suna Oguz
(S)
Sylwia Marciniak
(S)
Tanja Karen
(T)
Tomasz Szczapa
(T)
Tone Nordvik
(T)
Veronika Karadyova
(V)
Xiaoyan Gao
(X)
Xin Xu
(X)
Zachary Vesoulis
(Z)
Zhang Peng
(Z)
Zhaoqing Yin
(Z)
Informations de copyright
© 2024. The Author(s).
Références
Jeglic E, Kobak KA, Engelhardt N, Williams JB, Lipsitz JD, Salvucci D, et al. A novel approach to rater training and certification in multinational trials. Int Clin Psychopharmacol. 2007;22(4):187–91.
doi: 10.1097/YIC.0b013e3280803dad
pubmed: 17519640
Kobak KA, Engelhardt N, Lipsitz JD. Enriched rater training using Internet based technologies: a comparison to traditional rater training in a multi-site depression trial. J Psychiatr Res. 2006;40(3):192–9.
doi: 10.1016/j.jpsychires.2005.07.012
pubmed: 16197959
Kobak KA, Lipsitz J, Williams JB, Engelhardt N, Jeglic E, Bellew KM. Are the effects of rater training sustainable? Results from a multicenter clinical trial. J Clin Psychopharmacol. 2007;27(5):534–5.
doi: 10.1097/JCP.0b013e31814f4d71
pubmed: 17873701
Kobak KA, Lipsitz JD, Williams JB, Engelhardt N, Bellew KM. A new approach to rater training and certification in a multicenter clinical trial. J Clin Psychopharmacol. 2005;25(5):407–12.
doi: 10.1097/01.jcp.0000177666.35016.a0
pubmed: 16160614
Walker R, Morris DW, Greer TL, Trivedi MH. Research staff training in a multisite randomized clinical trial: Methods and recommendations from the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) trial. Addict Res Theory. 2014;22(5):407–15.
doi: 10.3109/16066359.2013.868446
pubmed: 25379036
Hansen ML, Rasmussen MI, Rubin S, Pellicer A, Cheng G, Xu X, et al. Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III. Trials. 2020;21(1):356.
doi: 10.1186/s13063-020-4206-6
pubmed: 32326953
pmcid: 7181533
Hansen ML, Pellicer A, Hyttel-Sorensen S, Ergenekon E, Szczapa T, Hagmann C, et al. Cerebral Oximetry Monitoring in Extremely Preterm Infants. N Engl J Med. 2023;388(16):1501–11.
doi: 10.1056/NEJMoa2207554
pubmed: 37075142
Antonoff MB, Verrier ED, Allen MS, Aloia L, Baker C, Fann JI, et al. Impact of Moodle-Based Online Curriculum on Thoracic Surgery In-Training Examination Scores. Ann Thorac Surg. 2016;102(4):1381–6.
doi: 10.1016/j.athoracsur.2016.03.100
pubmed: 27262911
Marques-Sule E, Sanchez-Gonzalez JL, Carrasco JJ, Perez-Alenda S, Sentandreu-Mano T, Moreno-Segura N, et al. Effectiveness of a blended learning intervention in cardiac physiotherapy. A randomized controlled trial. Front Public Health. 2023;11:1145892.
doi: 10.3389/fpubh.2023.1145892
pubmed: 37228724
pmcid: 10203476
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
doi: 10.1191/1478088706qp063oa
Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350:h2147.
doi: 10.1136/bmj.h2147
pubmed: 25956159
Hyttel-Sorensen S, Pellicer A, Alderliesten T, Austin T, van Bel F, Benders M, et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ. 2015;350:g7635.
doi: 10.1136/bmj.g7635
pubmed: 25569128
pmcid: 4283997